Background: The rise within the variety of most cancers circumstances and the evolution of most cancers care administration have turn out to be a big downside for the French well being care system, thereby making affected person empowerment as a protracted sought-after purpose in continual pathologies. The implementation of an activation measure through the Affected person Activation Measure-13 merchandise (PAM-13) in the midst of most cancers care can probably spotlight the affected person’s wants, with nursing care adapting accordingly.

Goal: The goals of this PARACT (PARAmedical Interventions on Affected person ACTivation) multicentric research have been as follows: (1) consider the implementation of PAM-13 in oncology nursing practices in 5 complete most cancers facilities, (2) determine the obstacles and facilitators to the implementation of PAM-13, and (3) produce suggestions for the dissemination of such interventions in different complete most cancers facilities.

Strategies: This research will comply with the “Attain, Effectiveness, Adoption, Implementation, and Upkeep” framework and can consist of three phases. First, a strong preimplementation evaluation will probably be performed utilizing the Theoretical Domains Framework (TDF) linked to the “Functionality, Alternative, Motivation, and Conduct” mannequin to determine the obstacles and facilitators to implementing new nursing practices in every context. Then, utilizing the Conduct Change Wheel, we are going to personalize a technique for implementing the PAM-13, relying on the specificities of every context, to encourage acceptability by the nursing employees concerned within the mission. This evaluation will probably be carried out through a qualitative research by way of semistructured interviews.

Second, the affected person will probably be included within the research for 12 months, throughout which the affected person care pathway will probably be studied, significantly to gather all related contacts of oncology nurses and different well being professionals concerned within the pathway. The axes of nursing care may even be collected. The first purpose is to implement PAM-13. Secondary elements to be measured are the affected person’s nervousness stage, high quality of life, and well being literacy stage. The oncology nurses will probably be liable for finishing the questionnaires when the affected person is on the hospital for his/her intravenous chemotherapy/immunotherapy remedy. The questionnaires will probably be accomplished thrice in a 12 months: (1) on the time of the affected person’s enrollment, (2) at 6 months, and (3) at 12 months. Third, a postimplementation evaluation will probably be carried out by way of semistructured interviews utilizing the TDF to research the implementation issues at every website.

Outcomes: This research was supported by a grant from the French Ministry of Well being (PHRIP PARACT 2016-0405) and the Lucien Neuwirth Institute of Cancerology of Saint-Etienne, France. Knowledge assortment for this research is ongoing.

Conclusions: This research would enhance the carried out focused nursing interventions in most cancers facilities so {that a} affected person is obtainable a customized most cancers care pathway. Moreover, measuring the extent of activation and the implementation of measures meant to extend such activation may represent a big benefit in decreasing social well being inequalities.

In lots of cancers, tumour development is related to elevated tissue stiffness. But, the mechanisms associating tissue stiffness with tumorigenesis and malignant transformation are unclear. Right here we present that in gastric most cancers cells, the stiffness of the extracellular matrix reversibly regulates the DNA methylation of the promoter area of the mechanosensitive Sure-associated protein (YAP). Reciprocal interactions between YAP and the DNA methylation inhibitors GRHL2, TET2 and KMT2A may cause hypomethylation of the YAP promoter and stiffness-induced oncogenic activation of YAP.

Human Cancer Antigen 15-3 (CA 15-3) ELISA Kit
PRB-5069	Cell Biolabs	96 assays	EUR 686.4

Human Cancer Antigen 15-3 (CA 15-3) ELISA Kit
PRB-5069-5	Cell Biolabs	5 x 96 assays	EUR 2739.6

Cancer Antigen 15-3 MUC 1 Antigen (Human Milk)
VAng-Cr3871-10kU	Creative Biolabs	10 kU	EUR 505.2
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Milk. The purity is detected by salt extraction and delipidization following high speed centrifugation. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Paraffin Tissue Section - Human Breast Tumor: Lobular carcinoma
T2235086-3	Biochain	5 slides	EUR 308.4
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Breast Cancer-Associated Antigen BRCAA1 (BRCAA1) Antibody
20-abx148333	Abbexa	EUR 510.00 EUR 410.40	100 ug 50 ug

BSA (Standard Grade)
30-AB70	Fitzgerald	1 kg	EUR 1078.8
Description: Standard Grade Bovine Serum Albumin (99% pure)

Cancer Antigen 15-3 MUC 1 Antigen (Human Ascites Fluid)
VAng-Cr3872-10kU	Creative Biolabs	10 kU	EUR 1363.2
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Ascites Fluid.

Cancer Antigen CA 15-3 Protein (Human Fluids)
VAng-Wyb8628-inquire	Creative Biolabs	inquire	Ask for price
Description: CA 15-3 (Breast Cancer Antigen), Cancer antigen from Human Fluids, 12.240 kU/mL.

Cancer Antigen CA 15-3 Protein (Human Milk)
VAng-Wyb8631-inquire	Creative Biolabs	inquire	Ask for price
Description: CA 15-3 (Breast Cancer Antigen), Antigen Grade, Cancer antigen from Human Milk, 33.0 kIU/mL.

Breast Cancer Exosome
P141-BR	101Bio	-	Ask for price

Organic Wine Standard 3
WINE-3	Scientific Laboratory Supplies	1ML	EUR 258.78

Paraffin Tissue Section - Human Brain Tumor: Astrocytoma Grade III
T2235035-3	Biochain	5 slides	EUR 308.4
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Cancer Antigen 15-3 (CA15-3) (human) ELISA Kit
K4804-100	Biovision	100 assays	EUR 1000.8
Description: Sensitive, Colorimetric Assay

Human Cancer PrimaCell4: Breast Tumor Cells Growth Medium
9-46027	CHI Scientific	5 x 100 ml	Ask for price

Human Cancer Tissue Preparation Buffer 4: Breast Tumor Cells
9-80027	CHI Scientific	1 x 100 ml	Ask for price

Breast Cancer Exosome RNA
P241-BR	101Bio	-	Ask for price

Fluorescent Exosome Standard (Urine )
ESF-15	Creative Biolabs	100 µg	EUR 2067.6
Description: Fluorescent exosomes are labeled with green dye, which offer a stable fluorescent labeling.

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
DLR-CA15-3-Hu-48T	DL Develop	48T	EUR 574.8
Description: A sandwich quantitative ELISA assay kit for detection of Human Carbohydrate Antigen 15-3 (CA15-3) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
DLR-CA15-3-Hu-96T	DL Develop	96T	EUR 745.2
Description: A sandwich quantitative ELISA assay kit for detection of Human Carbohydrate Antigen 15-3 (CA15-3) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids.

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RDR-CA15-3-Hu-48Tests	Reddot Biotech	48 Tests	EUR 600

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RDR-CA15-3-Hu-96Tests	Reddot Biotech	96 Tests	EUR 830.4

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RD-CA15-3-Hu-48Tests	Reddot Biotech	48 Tests	EUR 573.6

Human Carbohydrate Antigen 15-3 (CA15-3) ELISA Kit
RD-CA15-3-Hu-96Tests	Reddot Biotech	96 Tests	EUR 794.4

99445-15 DCT 15 X 85MM
99445-15	CORNING	250/pk	EUR 116.4
Description: Disposable Culture Tubes; DCT's, CGW

ICP-MS Calibration Standard 3
CL-CAL-3	Scientific Laboratory Supplies	125ML	EUR 121.98

Proteinase K, Recombinant, Standard Grade
9250-100	Biovision		EUR 124.8

Proteinase K, Recombinant, Standard Grade
9250-10G	Biovision		EUR 4627.2

Proteinase K, Recombinant, Standard Grade
9250-1G	Biovision		EUR 548.4

Proteinase K, Recombinant, Standard Grade
9250-500	Biovision		EUR 314.4

Proteinase K, Recombinant, Standard Grade
9251-100	Biovision		EUR 1266

Proteinase K, Recombinant, Standard Grade
9251-25	Biovision		EUR 352.8

Proteinase K, Recombinant, Standard Grade
9251-5	Biovision		EUR 144

Cancer Antigen 242 Antigen
VAng-Cr3876-10kU	Creative Biolabs	10 kU	EUR 505.2
Description: Cancer Antigen 242 Antigen, Host/Source: Metastatic Liver. The purity is detected by gel filtration.

Cancer Antigen 50 Antigen
VAng-Cr3877-50kU	Creative Biolabs	50 kU	EUR 6642
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

CA 15-3, Human Breast Adenocarcinoma
P1435-1	Biovision		EUR 130.8

CA 15-3, Human Breast Adenocarcinoma
P1435-5	Biovision		EUR 288

Polystyrene Particle Size Standard
PPS-3	Spherotech	mL	EUR 152.4
Description: Please reffer to the technical data sheet for more detail information for this item. Our dedicated team would be happy to assist you via live chat, email or phone.

Inactivated CMV Grade 3 Antigen
VAng-Lsx0038-1mg	Creative Biolabs	1 mg	EUR 2503.2
Description: CMV Grade 3, natural protein.

Inactivated MuV Grade 3 Antigen
VAng-Lsx0411-inquire	Creative Biolabs	inquire	Ask for price
Description: MuV grade 3, native protein.

Inactivated Rotavirus Grade 3 Antigen
VAng-Lsx0469-inquire	Creative Biolabs	inquire	Ask for price
Description: Rotavirus Grade 3, native virus.

Inactivated RuV Grade 3 Antigen
VAng-Lsx0476-1mL	Creative Biolabs	1 mL	EUR 474
Description: RuV Grade 3, natural protein.

Breast Cancer Metastasis Suppressor 1
PR27265	Neuromics	2 ug	EUR 229.2

ICP-MS Instrument Check Standard 3
CL-ICS-3	Scientific Laboratory Supplies	125ML	EUR 175.56

Breast Tumor Kinase antibody
70R-31875	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal Breast Tumor Kinase antibody

Breast Tumor Kinase antibody
70R-33385	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal Breast Tumor Kinase antibody

Breast Tissue Lysate (Tumor)
1713-01	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1713-02	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-01	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-02	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-03	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-04	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-05	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-06	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Breast Tissue Lysate (Tumor)
1714-07	ProSci	0.1 mg	EUR 336.3
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol.

Human Breast Tumor lysate
HTL-1323	Alpha Diagnostics	1 mg	EUR 927.6

Breast Membrane Tumor Lysate
XBL-10499	ProSci	0.1 mg	EUR 752.1
Description: Human breast tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human breast tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated breast tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated breast tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Cancer Antigen 72-4 Antigen
VAng-Cr3878-10kU	Creative Biolabs	10 kU	EUR 505.2
Description: Cancer Antigen 72-4 Antigen, Host/Source: Metastatic Liver. The purity is ~65% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Microplate cell grade 96well ps standard
781965	Scientific Laboratory Supplies	PK50	EUR 347.47

Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody
20-abx171475	Abbexa	EUR 1028.40 EUR 526.80	1 mg 200 ug

Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
20-abx133658	Abbexa	EUR 360.00 EUR 526.80 EUR 226.80	100 ul 200 ul 30 ul

Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody
20-abx129227	Abbexa	EUR 510.00 EUR 159.60 EUR 1446.00 EUR 693.60 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
20-abx013807	Abbexa	EUR 376.80 EUR 117.60 EUR 477.60 EUR 594.00	100 ug 10 ug 200 ug 300 µg

Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
abx025588-400ul	Abbexa	400 ul	EUR 627.6

Breast Cancer-Associated Gene 3 Protein (BCA3) Antibody
abx025588-80l	Abbexa	80 µl	EUR 343.2

Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Antibody
20-abx324781	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Recombinant Breast Cancer Anti-Estrogen Resistance 3 (BCAR3)
4-RPG768Hu01	Cloud-Clone	EUR 601.69 EUR 284.40 EUR 1926.34 EUR 722.11 EUR 1324.22 EUR 477.60 EUR 4635.84	100 ug 10ug 1 mg 200 ug 500 ug 50ug 5 mg
Description: Recombinant Human Breast Cancer Anti-Estrogen Resistance 3 expressed in: E.coli

Human CA15-3 Antigen Grade Protein
abx060972-250kU	Abbexa	250 kU	EUR 2380.8

Inactivated PIV-3 Grade 2 Antigen
VAng-Wyb3637-1mL	Creative Biolabs	1 mL	EUR 1363.2
Description: Parainfluenza virus type 3 (strain C243) Grade 2, natural antigen

Inactivated HSV-1 Grade 3 Antigen
VAng-Lsx0293-1mg	Creative Biolabs	1 mg	EUR 1786.8
Description: HSV Type 1 Grade III, native antigen.

Inactivated HSV-2 Grade 3 Antigen
VAng-Lsx0302-1mg	Creative Biolabs	1 mg	EUR 1786.8
Description: HSV Type 2 Grade III, native antigen.

Breast Cancer Metastasis Suppressor 1 Protein
20-abx263402	Abbexa	EUR 1930.80 EUR 393.60 EUR 276.00	100 ug 10 ug 2 µg

Autobioluminescent Human Breast Cancer Cells (MCF7)
ASE-5903	Applied StemCell	1 ml	EUR 2490
Description: 6 month

Autobioluminescent Human Breast Cancer Cells (T47D)
ASE-5904	Applied StemCell	1 ml	EUR 2490
Description: 6 month

Human Breast Cancer Signaling Primer Library
HBRCA-I	Real Time Primers	1 set	EUR 657.6

Breast Cancer Anti-Estrogen Resistance 1
PR27245	Neuromics	2 ug	EUR 229.2

Anti-Breast Cancer Resistance Protein antibody
STJ16100903	St John's Laboratory	1 mL	EUR 573.6

Anti-Breast Cancer Resistance Protein antibody
STJ16100916	St John's Laboratory	1 mL	EUR 573.6

anti-Breast cancer suppressor candidate 1
YF-PA24096	Abfrontier	50 ul	EUR 400.8
Description: Mouse polyclonal to Breast cancer suppressor candidate 1

anti-Breast cancer suppressor candidate 1
YF-PA12974	Abfrontier	50 ul	EUR 435.6
Description: Mouse polyclonal to Breast cancer suppressor candidate 1

anti-Breast cancer suppressor candidate 1
YF-PA12975	Abfrontier	50 ug	EUR 435.6
Description: Mouse polyclonal to Breast cancer suppressor candidate 1

Prostate Specific Antigen Std Grade Antigen
VAng-Cr3891-1mg	Creative Biolabs	1 mg	EUR 604.8
Description: Prostate Specific Antigen Std Grade Antigen, Host/Source: Human Seminal Fluid. The purity is detected by salt precipitation.

CEA Antigen Grade Protein
abx060976-05mg	Abbexa	0.5 mg	EUR 1161.6

CEA Antigen Grade Protein
abx060977-1mg	Abbexa	1 mg	EUR 2030.4

Pesticide Mix 3 Containing 15 Compounds in Acetonitrile
SPXPR-3	Scientific Laboratory Supplies	1ML	EUR 214.32

9998 SCREW CAP 415/15
9998-15	CORNING	288/pk	EUR 237.6
Description: General Apparatus; Stoppers

Breast Tumor Tissue Array - 16 cases of breast cancer, each in duplicates, paired with adjacent normal tissues
Z7020007	Biochain	5 slides	EUR 1657.2
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Human Cancer Antigen CA15-3 Protein
abx060965-50kU	Abbexa	50 kU	EUR 3150

Groundwater and Wastewater Pollution Control Check Standard
WP-3	Scientific Laboratory Supplies	125ML	EUR 112.86

Cancer Antigen 125 Antigen (Human Adenocarcinoma)
VAng-Cr3868-10kU	Creative Biolabs	10 kU	EUR 505.2
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography.

Cancer Antigen 125 Antigen (Ascites Fluid)
VAng-Cr3870-10kU	Creative Biolabs	10 kU	EUR 1132.8
Description: Cancer Antigen 125 Antigen, Host/Source: Ascites Fluid. The purity is ≥ 95% by SDS-PAGE.

Cancer Antigen CEA Antigen (Human Fluids)
VAng-Wyb8644-inquire	Creative Biolabs	inquire	Ask for price
Description: Carcinoembryonic Antigen, Calibrator Grade, Cancer antigen from Human Fluids, 1.13 mg/mL.

Breast Tumor Kinase Blocking Peptide
AF4768-BP	Affbiotech	1mg	EUR 234

Breast Tumor Kinase antibody (Tyr447)
70R-33384	Fitzgerald	100 ug	EUR 392.4
Description: Rabbit polyclonal Breast Tumor Kinase antibody (Tyr447)

Human Tumor Tissue: Breast cDNA
HT05-090	Alpha Diagnostics	10 rxn	EUR 498

Human Cancer Antigen CA125 (Ovarian Cancer) Protein
abx061590-100kU	Abbexa	100 kU	EUR 1446

Vitamin A Reference Standard (USP grade powder)
51R-U716002	Fitzgerald	10 pack	EUR 619.2
Description: Vitamin A Reference Standard (USP grade powder) chemical reference substance

Anti-Rabbit Whole Serum | GWS-15
GWS-15	Immunology Consultants Laboratory	1.0 mL	EUR 130
Description: Anti-Rabbit Whole Serum | GWS-15 | Immunology Consultants Laboratory Host: Goat Format: Whole Serum Product Type: Primary Antibody Antibody Clonality: Polyclonal

Liquid Wicks, Size 15, 200 /pk
W-15	MiTeGen	200 WICKS	EUR 22
Description: Liquid Wicks, Size 15, 200 /pk

Cancer of the breast, 75 cases (1.1mm), set 3
BRC1503	Pantomics	1	EUR 300
Description: Breast cancer tissue array, set 3, non-overlapping with BRC1501, BRC1502, BRC1504 to BRC15011,150 cores from normal/benign (5 cases) and cancer (70 cases) tissues in duplicates with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.

Human Breast Cancer Anti-Estrogen Resistance 3 (BCAR3) Protein
20-abx168253	Abbexa	EUR 844.80 EUR 343.20 EUR 2598.00 EUR 994.80 EUR 594.00	100 ug 10 ug 1 mg 200 ug 50 ug

Breast Cancer Anti-Estrogen Resistance Protein 3 (BCAR3) Antibody
20-abx134976	Abbexa	EUR 427.20 EUR 644.40 EUR 260.40	100 ul 200 ul 30 ul

Breast Cancer Anti-Estrogen Resistance Protein 3 (BCAR3) Antibody
abx010337-100ug	Abbexa	100 ug	EUR 526.8

Breast Cancer Anti-Estrogen Resistance Protein 3 (BCAR3) Antibody
abx432398-200ul	Abbexa	200 ul	EUR 460.8

Breast Cancer Anti-Estrogen Resistance Protein 3 (BCAR3) Antibody
abx218562-100ug	Abbexa	100 ug	EUR 526.8

Breast Cancer Estrogen Resistance 3 (BCAR3) Polyclonal Antibody (Human)
4-PAG768Hu01	Cloud-Clone	EUR 296.40 EUR 3012.00 EUR 750.00 EUR 372.00 EUR 256.80	100ul 10ml 1ml 200ul 20ul
Description: A Rabbit polyclonal antibody against Human Breast Cancer Estrogen Resistance 3 (BCAR3)

Paraffin Tissue Section - Human Pancreas Tumor: Islet Cell Tumor
T2235188-3	Biochain	5 slides	EUR 308.4
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Recombinant Human IL-15 Protein
PROTP40933-3	BosterBio	10ug	EUR 380.4
Description: IL-15 is an immunomodulating cytokine that stimulates the proliferation of T lymphocytes and shares many biological properties with IL-2. IL-15 exerts its biological activites primarily on T cells. It is also essential in the development, survival and activation of NK cells. Increased expression of IL-15 has been implicated with rheumatoid arthritis, inflammatory bowel disease and diseases affiliated with retroviruses HIV and HTLV-I. Human IL-15 is biologically active on mouse cells as measured by the dose-dependent stimulation of the proliferation of mouse CTLL cells. Recombinant human IL-15 is a 12.9 kDa protein consisting of 114 amino acid residues.

Swine IL-15 Recombinant Protein
R00212-3	BosterBio	5ug/vial	EUR 310.8
Description: Interleukin-15 (IL-15) is a cytokine with structural similarity to IL-2 that is secreted by mononuclear phagocytes following infection by virus(es). This cytokine induces cell proliferation of natural killer cells. Swine IL-15 Recombinant Protein is purified interleukin-15 produced in yeast.

Paraffin Tissue Section - Human Breast Tumor: Male Breast Hyperplasia
T2235086-4	Biochain	5 slides	EUR 308.4
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Paraffin Tissue Section - Human Breast Tumor: Medullarycarcinoma of Breast
T2235086-5	Biochain	5 slides	EUR 308.4
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Inactivated MuV Grade 3 Antigen (Strain Enders)
VAng-0619Lsx-inquire	Creative Biolabs	inquire	Ask for price
Description: MuV (Strain Enders) grade 3, native protein. 0.45 mg/mL.

Human Breast cancer metastasis-suppressor 1 (BRMS1)
1-CSB-RP048144h	Cusabio	EUR 456.00 EUR 256.80 EUR 1570.80 EUR 672.00 EUR 1047.60 EUR 314.40	100ug 10ug 1MG 200ug 500ug 50ug
Description: Recombinant Human Breast cancer metastasis-suppressor 1(BRMS1),partial expressed in E.coli

Cancer of the breast, 102 cases (1.5mm)
BRC1021	Pantomics	1	EUR 300
Description: Breast cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases) tissues, with grading, TNM staging, and AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.

Cancer of the breast, 228 cases (1.1mm)
BRC2281	Pantomics	1	EUR 552
Description: Breast cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading, TNM staging, and AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.

Cancer of the breast, 49 cases (2mm)
BRC491	Pantomics	1	EUR 228
Description: Breast cancer tissue array, non-overlapping with BRC711, 49 cases of normal/benign and cancer tissues with grading, TNM staging, and AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.

Cancer of the breast, 71 cases (1.1mm)
BRC711	Pantomics	1	EUR 228
Description: Breast cancer tissue array, non-overlapping with BRC491, 71 cases of normal/benign and cancer tissues with grading, TNM staging data, AR, ER, PR, HER2, P53, EGFR, Ki67 IHC data.

Breast cancer-overexpressed gene 1 protein Antibody
48092-100ul	SAB	100ul	EUR 399.6

Breast cancer-overexpressed gene 1 protein Antibody
48092-50ul	SAB	50ul	EUR 286.8

Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody
20-abx104049	Abbexa	EUR 493.20 EUR 159.60 EUR 1378.80 EUR 678.00 EUR 376.80	100 ug 10 ug 1 mg 200 ug 50 ug

Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody
20-abx104050	Abbexa	EUR 526.80 EUR 159.60 EUR 1496.40 EUR 710.40 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody
20-abx104051	Abbexa	EUR 493.20 EUR 159.60 EUR 1378.80 EUR 678.00 EUR 376.80	100 ug 10 ug 1 mg 200 ug 50 ug

Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody
20-abx171476	Abbexa	EUR 978.00 EUR 510.00	1 mg 200 ug

Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody
20-abx171477	Abbexa	EUR 978.00 EUR 510.00	1 mg 200 ug

Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody
20-abx175628	Abbexa	EUR 1412.40 EUR 693.60	1 mg 200 ug

Breast Cancer Cell Protein 2 (BRCC2) Antibody
20-abx141388	Abbexa	EUR 444.00 EUR 727.20 EUR 360.00	100 ul 200 ul 50 ul

Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody
20-abx130340	Abbexa	EUR 526.80 EUR 159.60 EUR 1479.60 EUR 710.40 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

Breast Cancer Susceptibility Protein 1 (BRCA1) Antibody
20-abx129675	Abbexa	EUR 510.00 EUR 159.60 EUR 1412.40 EUR 693.60 EUR 393.60	100 ug 10 ug 1 mg 200 ug 50 ug

Breast Cancer Susceptibility Protein 2 (BRCA2) Antibody
20-abx129746	Abbexa	EUR 360.00 EUR 159.60 EUR 961.20 EUR 510.00 EUR 309.60	100 ug 10 ug 1 mg 200 ug 50 ug

Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
20-abx008216	Abbexa	EUR 360.00 EUR 526.80 EUR 226.80	100 ul 200 ul 30 ul

Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
20-abx008217	Abbexa	EUR 360.00 EUR 526.80 EUR 226.80	100 ul 200 ul 30 ul

Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
abx030985-400ul	Abbexa	400 ul	EUR 627.6

Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
abx030985-80l	Abbexa	80 µl	EUR 343.2

Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
abx230960-100ug	Abbexa	100 ug	EUR 577.2

Breast Cancer Anti-Estrogen Resistance 1 Protein
20-abx262743	Abbexa	EUR 393.60 EUR 7676.40 EUR 276.00	10 ug 1 mg 2 µg

Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
20-abx327442	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
20-abx328607	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
20-abx241361	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Breast Cancer Metastasis-Suppressor 1 (BRMS1) Antibody
20-abx241362	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

SNCG (breast cancer-specific protein 1) Antibody
BF0110	Affbiotech	200ul	EUR 540

Anti-Human Breast Cancer Resistance Protein antibody
STJ16100907	St John's Laboratory	1 mL	EUR 573.6

Anti-Mouse Breast Cancer Resistance Protein antibody
STJ16100917	St John's Laboratory	1 mL	EUR 573.6

Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2)
4-RPB364Hu01	Cloud-Clone	EUR 636.10 EUR 294.00 EUR 2055.36 EUR 765.12 EUR 1410.24 EUR 501.60 EUR 4958.40	100 ug 10ug 1 mg 200 ug 500 ug 50ug 5 mg
Description: Recombinant Human Breast Cancer Susceptibility Protein 2 expressed in: E.coli

Direct alteration of extracellular cues through in situ matrix softening reversed YAP exercise and the epigenetic program. Our findings recommend that epigenetic reprogramming of the mechanophysical properties of the extracellular microenvironment of stable tumours might symbolize a therapeutic technique for the inhibition of most cancers development.